AAUM (Average Assets Under Management) of ₹3,199.22 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 61.4% | 60.4% | ▼ -1.0% |
| Healthcare Services | 12.7% | 14.3% | ▲ +1.5% |
| Insurance | 1.3% | 1.2% | ▼ -0.1% |
| Healthcare Equipment & Supplies | 0.2% | 0.2% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 60.4% | 65.1% | ▲ +4.6% |
| Healthcare Services | 14.3% | 18.0% | ▲ +3.8% |
| Insurance | 1.2% | 1.1% | ▼ -0.1% |
| Healthcare Equipment & Supplies | 0.2% | 0.2% | ● 0.0% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Manipal Health Enterprises Ltd ₹109.71 Cr |
Healthcare Services | 3.02% |
| 2 | Divi's Laboratories Limited ₹84.79 Cr |
Pharmaceuticals & Biotechnology | 2.34% |
| 3 | Eris Lifesciences Limited ₹30.60 Cr |
Pharmaceuticals & Biotechnology | 0.84% |
| 4 | Jupiter Life Line Hospitals Limited ₹17.12 Cr |
Healthcare Services | 0.47% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | Jupiter Life Line Hospitals Ltd ₹13.37 Cr |
Healthcare Services | 0.38% |
| 2 | Emcure Pharmaceuticals Limited ₹12.85 Cr |
Pharmaceuticals & Biotechnology | 0.37% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Alkem Laboratories Limited ₹169.01 Cr |
Pharmaceuticals & Biotechnology | 2.61% | 4.66% | +2.05% |
| 2 | Apollo Hospitals Enterprise Limited ₹210.88 Cr |
Healthcare Services | 4.81% | 5.81% | +1.00% |
| 3 | Sun Pharmaceutical Industries Limited ₹305.66 Cr |
Pharmaceuticals & Biotechnology | 8.14% | 8.42% | +0.28% |
| 4 | Sai Life Sciences Limited ₹257.41 Cr |
Pharmaceuticals & Biotechnology | 6.88% | 7.10% | +0.22% |
| 5 | Pfizer Limited ₹99.22 Cr |
Pharmaceuticals & Biotechnology | 2.53% | 2.73% | +0.20% |
| 6 | Concord Biotech Limited ₹70.57 Cr |
Pharmaceuticals & Biotechnology | 1.81% | 1.95% | +0.14% |
| 7 | Unichem Laboratories Ltd. ₹57.73 Cr |
Pharmaceuticals & Biotechnology | 1.46% | 1.59% | +0.13% |
| 8 | Aarti Drugs Ltd ₹36.02 Cr |
Pharmaceuticals & Biotechnology | 0.92% | 0.99% | +0.07% |
| 9 | Procter & Gamble Health Limited ₹105.20 Cr |
Pharmaceuticals & Biotechnology | 2.87% | 2.90% | +0.03% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Cohance Lifesciences Limited ₹136.14 Cr |
Pharmaceuticals & Biotechnology | 4.13% | 3.75% | -0.38% |
| 2 | Indoco Remedies Ltd ₹71.24 Cr |
Pharmaceuticals & Biotechnology | 2.21% | 1.96% | -0.25% |
| 3 | Cipla Limited ₹294.84 Cr |
Pharmaceuticals & Biotechnology | 8.35% | 8.13% | -0.22% |
| 4 | Alembic Pharmaceuticals Limited ₹114.98 Cr |
Pharmaceuticals & Biotechnology | 3.38% | 3.17% | -0.21% |
| 5 | Gland Pharma Limited ₹230.44 Cr |
Pharmaceuticals & Biotechnology | 6.54% | 6.35% | -0.19% |
| 6 | Vijaya Diagnostic Centre Limited ₹125.77 Cr |
Healthcare Services | 3.60% | 3.47% | -0.13% |
| 7 | Kovai Medical Center and Hospital Limited ₹99.29 Cr |
Healthcare Services | 2.87% | 2.74% | -0.13% |
| 8 | ICICI Lombard General Insurance Company Limited ₹39.20 Cr |
Insurance | 1.20% | 1.08% | -0.12% |
| 9 | Syngene International Limited ₹48.22 Cr |
Healthcare Services | 1.38% | 1.33% | -0.05% |
| 10 | IPCA Laboratories Limited ₹296.49 Cr |
Pharmaceuticals & Biotechnology | 8.21% | 8.17% | -0.04% |
25 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹305.66 Cr |
Pharmaceuticals & Biotechnology |
8.42%
|
|
| 2 |
₹296.49 Cr |
Pharmaceuticals & Biotechnology |
8.17%
|
|
| 3 |
₹294.84 Cr |
Pharmaceuticals & Biotechnology |
8.13%
|
|
| 4 |
₹257.41 Cr |
Pharmaceuticals & Biotechnology |
7.10%
|
|
| 5 |
₹230.44 Cr |
Pharmaceuticals & Biotechnology |
6.35%
|
|
| 6 |
₹210.88 Cr |
Healthcare Services |
5.81%
|
|
| 7 |
₹169.01 Cr |
Pharmaceuticals & Biotechnology |
4.66%
|
|
| 8 |
₹136.14 Cr |
Pharmaceuticals & Biotechnology |
3.75%
|
|
| 9 |
₹125.77 Cr |
Healthcare Services |
3.47%
|
|
| 10 |
₹114.98 Cr |
Pharmaceuticals & Biotechnology |
3.17%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.